These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 26319372)

  • 1. SRFBP1, an Additional Player in HCV Entry.
    Fénéant L; Cocquerel L
    Trends Microbiol; 2015 Oct; 23(10):590-593. PubMed ID: 26319372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry.
    Gerold G; Meissner F; Bruening J; Welsch K; Perin PM; Baumert TF; Vondran FW; Kaderali L; Marcotrigiano J; Khan AG; Mann M; Rice CM; Pietschmann T
    Cell Rep; 2015 Aug; 12(5):864-78. PubMed ID: 26212323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD81 and hepatitis C virus (HCV) infection.
    Fénéant L; Levy S; Cocquerel L
    Viruses; 2014 Feb; 6(2):535-72. PubMed ID: 24509809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
    Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
    Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
    Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.
    Bruening J; Lasswitz L; Banse P; Kahl S; Marinach C; Vondran FW; Kaderali L; Silvie O; Pietschmann T; Meissner F; Gerold G
    PLoS Pathog; 2018 Jul; 14(7):e1007111. PubMed ID: 30024968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
    Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
    Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
    Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
    Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
    Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
    Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
    Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
    Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
    PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of HCV entry into host cells.
    Douam F; Lavillette D; Cosset FL
    Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD81 is an entry coreceptor for hepatitis C virus.
    Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPII cargo claudin-12 promotes hepatitis C virus entry.
    Huang J; Yin P; Zhang L
    J Viral Hepat; 2019 Feb; 26(2):308-312. PubMed ID: 30339745
    [No Abstract]   [Full Text] [Related]  

  • 16. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus entry: role of host and viral factors.
    Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
    Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Structural Tuning of the Hepatitis C Virus Human Cellular Receptor CD81 Large Extracellular Loop.
    Cunha ES; Sfriso P; Rojas AL; Roversi P; Hospital A; Orozco M; Abrescia NGA
    Structure; 2017 Jan; 25(1):53-65. PubMed ID: 27916518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.
    Liu R; Tewari M; Kong R; Zhang R; Ingravallo P; Ralston R
    Antiviral Res; 2010 May; 86(2):172-9. PubMed ID: 20156485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
    J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.